Showing results (51-60 of 232) with videos related to
Sort By:
Pageof 24
Clinical Immunology and Immunopathology|July 1, 1984
Potentiation of Leu 11 + natural cytotoxicity by human interleukin 2E W Ades, A Hinson, P Marder, et al.The Tokai Journal of Experimental and Clinical Medicine|December 1, 1988
Interaction of Gc (vitamin-D binding protein) with membrane of activated natural cytolytic cellsE W Ades, D Bosse, J K Nicholson, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1982
Characterization of HNK-1+ (Leu-7) human lymphocytes. I. Two distinct phenotypes of human NK cells with different cytotoxic capabilityT Abo, M D Cooper, C M BalchCancer Research|June 1, 1986
Interleukin 2 activation of cytotoxic T-lymphocytes infiltrating into human metastatic melanomasK Itoh, A B Tilden, C M BalchCellular Immunology|August 1, 1988
Monocyte-independent interleukin-2 production and proliferation of human T cells in response to murine hybridomas expressing the OKT3 monoclonal antibody: interleukin-1 is not required for T-cell proliferationK Itoh, C M Balch, C D PlatsoucasEuropean Journal of Immunology|July 1, 1984
Characterization of human granular lymphocyte subpopulations expressing HNK-1 (Leu-7) and Leu-11 antigens in the blood and lymphoid tissues from fetuses, neonates and adultsT Abo, C A Miller, C M BalchCancer Immunology, Immunotherapy : CII|January 1, 1989
Monocyte-dependent, serum-borne suppressor of induction of lymphokine-activated killer cells in lymphocytes from melanoma patientsK Itoh, N R Pellis, C M BalchCancer Research|July 1, 1985
Role of interleukin 2 and a serum suppressive factor on the induction of activated killer cells cytotoxic for autologous human melanoma cellsK Itoh, A B Tilden, C M BalchCellular Immunology|September 1, 1987
Monocyte- and natural killer cell-mediated spontaneous cytotoxicity against human noncultured solid tumor cellsK Itoh, C D Platsoucas, C M BalchJournal of Immunology (Baltimore, Md. : 1950)|March 1, 1983
Suppressor cell function of human granular lymphocytes identified by the HNK-1 (Leu 7) monoclonal antibodyA B Tilden, T Abo, C M BalchPageof 24